EM
EMED.US Electromedical Technologies Inc
- Market cap
- USD 373K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is EMED.US undervalued?
Graham numberThe Graham number of Electromedical Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Electromedical Technologies Inc fundamental analysis
No fundamental analysis for Electromedical Technologies Inc yet.
Electromedical Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Electromedical Technologies Inc
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. It also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser use…
Full company profileElectromedical Technologies Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Electromedical Technologies Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 858K | 675K | 830K | 738K | 907K | 1.15M | 1.35M | 588K | 41.2K | 15.9K |
| Gross Profit | 660K | 484K | 591K | 544K | 708K | 889K | 1.05M | 381K | -62.2K | -33.5K |
| Operating Income | -457K | -281K | -1.67M | -3.17M | -3.80M | -1.60M | -2.06M | -1.06M | -1.02M | -965K |
| EBITDA | -434K | -1.84M | -1.67M | -3.08M | -5.14M | -2.66M | -1.72M | -1.01M | -916K | -965K |
| Net Income | -510K | -1.95M | -1.74M | -3.87M | -8.48M | -3.47M | -2.64M | -1.29M | -1.44M | -1.36M |
| EPS | -0.03 | -0.13 | -0.10 | -0.17 | -0.17 | -0.03 | -0.01 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 1.18M | 979K | 903K | 1.42M | 1.40M | 1.35M | 748K | 529K | 861K | 598K |
| Total Liabilities | 2.04M | 3.04M | 3.09M | 2.74M | 2.12M | 3.57M | 3.62M | 4.37M | 4.48M | 4.90M |
| Shareholders' Equity | -860K | -2.06M | -2.18M | -1.32M | -723K | -2.22M | -2.87M | -3.84M | -3.62M | -4.30M |
| Cash & Short-term Investments | 27.9K | - | 0.00 | 265K | 383K | 368K | 87.7K | 10.2K | 436K | 531.00 |
| Total Debt | 1.02M | 2.60M | 2.46M | 1.37M | 1.57M | 1.98M | 1.70M | 1.57M | 1.24M | 1.26M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -138K | -359K | -281K | -1.34M | -1.19M | -773K | -1.42M | -112K | -149K | -867K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 3.00 | 150K | 3.00 | 3.00 | 0.00 |
| Free Cash Flow | -138K | -359K | -281K | -1.34M | -1.19M | -773K | -1.57M | -112K | -149K | -867K |
| Ratios | ||||||||||
| ROA | -43.3% | -199.3% | -193.2% | -273.2% | -604.8% | -256.3% | -352.9% | -244.1% | -167.3% | -228.1% |
| Net Profit Margin | -59.5% | -288.8% | -210.2% | -524.7% | -934.6% | -301.6% | -195.8% | -219.6% | -3,495.3% | -8,596.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Electromedical Technologies Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 36.4K | 0.00 | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | USD 24.0K | 0.00 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Electromedical Technologies Inc
- Insiders 0.48%
- Institutions 0.00%
- Public & others 99.52%
- Shares outstanding 3.73B
- Free float 851M
Electromedical Technologies Inc company profile
- Company name
- Electromedical Technologies Inc
- Ticker
- EMED.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 6
- Fiscal year end
- December
- Address
- 16413 North 91st Street, Scottsdale, AZ, United States, 85260
- Phone
- 888 880 7888
- Website
- electromedtech.com
About Electromedical Technologies Inc
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. It also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. The company serves chiropractors, physiotherapists, pain management doctors and clinicians, natural medicine doctors, sports medicine doctors, and athletic trainers. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona.
Electromedical Technologies Inc management
5- Mr. Matthew N. WolfsonCEO, President, Chairman, CFO, Treasurer & Secretary · born 1972
- Mr. Petar GajicCIO, Director of Technology & Employee Director · born 1972
- Mr. Tad M. MailanderCounsel · born 1956
- Ms. Kathy Strand R.N.Director of Sales & Training
- Mr. Alexander A. PedenkoChief Medical Advisor